Buscar
Mostrando ítems 41-50 de 1395
Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease
(PERGAMON-ELSEVIER SCIENCE LTD, 2010)
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas
(Elsevier, 2022)
Non-alcoholic fatty liver disease (NAFLD) affects 20–25% of the general population and is associated with morbidity, increased mortality, and elevated health-care costs. Most NAFLD risk factors are modifiable and, therefore, ...
Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
(Elsevier Ireland, 2009-12)
Proper screening for cardiovascular risk and fatty liver disease will be critical in primary prevention and in the treatment of existing but undiagnosed cardiovascular and liver disease in young individuals. Accordingly, ...